Clinical Trials Directory

Trials / Completed

CompletedNCT07302191

High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women

Comparable Reductions in Health Biomarkers Following High-Intensity Interval or Concurrent Training in Obese Postmenopausal Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
University of Valladolid · Academic / Other
Sex
Female
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Introduction: Menopause is associated with body composition change, an increase in the cardio-metabolic risk factor for oxidative stress. Nevertheless, it has been suggested that regular physical training is an effective non-pharmacological intervention to reduce oxidative stress and cardio-metabolic disorders in menopausal individuals. Therefore, the present study was conducted to compare the effects of twelve weeks of high-intensity interval training (HIIT) and concurrent (Conc) and on body composition, cardio-metabolic indices and oxidative stress in sedentary obese postmenopausal women. Materials and methods: Forty-five menopausal obese women voluntarily participated and were randomly assigned into three groups: a) HIIT (6-12×60s of high intensity training (85-95% HRMax) and then running for 60 seconds with low intensity (55-60% HRMax)), b) concurrent endurance (performed on training with 55-75% HRMax) and strength training (including two sets in eight exercise stations with 55-75% 1RM)) and c) control group. Training programs were done for twelve weeks, 3 times per week. Body composition, cardio-metabolic indices and oxidative stress markers were measured before and after twelve weeks of exercise training program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHigh-Intensity IntervalHIIT consisted of alternating high- (90-95 % HR\_max) and low-intensity (55-60 % HR\_max) aerobic bouts
BEHAVIORALconcurrent trainingcombined aerobic and resistance exercises
BEHAVIORALControl Groupusual daily routines

Timeline

Start date
2025-09-02
Primary completion
2025-11-20
Completion
2025-12-08
First posted
2025-12-24
Last updated
2025-12-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07302191. Inclusion in this directory is not an endorsement.